FDAnews
www.fdanews.com/articles/119876-gpos-8217-dealings-with-manufacturers-come-under-senate-scrutiny

GPOs’ Dealings With Manufacturers Come Under Senate Scrutiny

August 24, 2009
Three Senate committees are questioning the way drugmakers do business with hospitals and other healthcare providers. Seven group purchasing organizations (GPOs) recently received a letter on behalf of the Senate Finance Committee, the Judiciary Committee’s Antitrust Subcommittee and the Special Committee on Aging, asking for details about GPO negotiation and administration of group purchasing agreements, contracts and sources of funding, sole-source contracts and negotiations for “bundled” client discounts, by Sept. 8.
Washington Drug Letter